Taysha Gene Therapies (TSHA) Earnings Analysis
Taysha Gene Therapies (TSHA) has no confirmed upcoming earnings date. In its last reported quarter (2026-03-19) TSHA beat analyst consensus (+27.3% EPS surprise). Trailing P/E -14.79.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does TSHA next report earnings?
No confirmed upcoming earnings date is currently scheduled for TSHA. This page updates as the calendar is published.
TSHA last-quarter earnings result
| Last reported quarter | 2026-03-19 |
|---|---|
| Result vs consensus | Beat (+27.3% EPS surprise) |
TSHA consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on TSHA
Frequently asked questions
When does TSHA next report earnings?
TSHA has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did TSHA beat earnings last quarter?
In its 2026-03-19 report, TSHA beat analyst consensus (+27.3% EPS surprise).
Where can I see TSHA analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for TSHA are in the SniperIQ app: https://app.sniperiq.ai/register